125 related articles for article (PubMed ID: 35804998)
1. Body Mass Index Is Inversely Associated with Risk of Postmenopausal Interval Breast Cancer: Results from the Women's Health Initiative.
Zhang Z; Curran G; Shannon J; Velie EM; Irvin VL; Manson JE; Simon MS; Altinok Dindar D; Pyle C; Schedin P; Tabung FK
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804998
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
3. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.
Chlebowski RT; Aragaki AK; Pan K; Simon MS; Neuhouser ML; Haque R; Rohan TE; Wactawski-Wende J; Orchard TS; Mortimer JE; Lane D; Kaunitz AM; Desai P; Wild RA; Barac A; Manson JE
Cancer; 2024 May; ():. PubMed ID: 38736319
[TBL] [Abstract][Full Text] [Related]
5. Weight loss and breast cancer incidence in postmenopausal women.
Chlebowski RT; Luo J; Anderson GL; Barrington W; Reding K; Simon MS; Manson JE; Rohan TE; Wactawski-Wende J; Lane D; Strickler H; Mosaver-Rahmani Y; Freudenheim JL; Saquib N; Stefanick ML
Cancer; 2019 Jan; 125(2):205-212. PubMed ID: 30294816
[TBL] [Abstract][Full Text] [Related]
6. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
[TBL] [Abstract][Full Text] [Related]
7. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
Morimoto LM; White E; Chen Z; Chlebowski RT; Hays J; Kuller L; Lopez AM; Manson J; Margolis KL; Muti PC; Stefanick ML; McTiernan A
Cancer Causes Control; 2002 Oct; 13(8):741-51. PubMed ID: 12420953
[TBL] [Abstract][Full Text] [Related]
8. Diet-Driven Inflammation and Insulinemia and Risk of Interval Breast Cancer.
Zhang Z; Tabung FK; Jin Q; Curran G; Irvin VL; Shannon J; Velie EM; Manson JE; Simon MS; Vitolins M; Valencia CI; Snetselaar L; Jindal S; Schedin P
Nutr Cancer; 2022; 74(9):3179-3193. PubMed ID: 35471124
[TBL] [Abstract][Full Text] [Related]
9. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
Tran TXM; Moon SG; Kim S; Park B
JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
[TBL] [Abstract][Full Text] [Related]
10. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
[TBL] [Abstract][Full Text] [Related]
11. The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative.
Arthur RS; Xue X; Kamensky V; Chlebowski RT; Simon M; Luo J; Shadyab AH; Neuhouser ML; Banack H; Ho GYF; Lane DS; Pan K; Reding KW; Wassertheil-Smoller S; Dannenberg AJ; Rohan TE
Cancer Med; 2020 Feb; 9(4):1581-1599. PubMed ID: 31875358
[TBL] [Abstract][Full Text] [Related]
12. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
13. Prospective breast cancer risk prediction model for women undergoing screening mammography.
Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
[TBL] [Abstract][Full Text] [Related]
14. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
[TBL] [Abstract][Full Text] [Related]
15. Temporal Associations and Outcomes of Breast Cancer and Heart Failure in Postmenopausal Women.
Lam PH; Barac A; Nohria A; Reding KW; Najjar SS; Fonarow GC; Pan K; Sheriff H; Morgan CJ; Chlebowski RT; Klein L; Eaton CB; Howard BV; Ahmed A; Mohammed SF
JACC CardioOncol; 2020 Nov; 2(4):567-577. PubMed ID: 34396268
[TBL] [Abstract][Full Text] [Related]
16. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
18. The association between metabolic health, obesity phenotype and the risk of breast cancer.
Park YM; White AJ; Nichols HB; O'Brien KM; Weinberg CR; Sandler DP
Int J Cancer; 2017 Jun; 140(12):2657-2666. PubMed ID: 28268252
[TBL] [Abstract][Full Text] [Related]
19. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
20. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
